Financials Sernova Corp. Toronto S.E.
Equities
SVA
CA81732W1041
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 CAD | +2.78% | -7.50% | -47.14% |
04-25 | Sernova Corp. Announces Board and Management Changes | CI |
04-25 | Sernova Corp. Announces Workforce Reduction | CI |
Valuation
Fiscal Period: October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 38.15 | 55.19 | 326.4 | 234.5 | 243.9 | 112.3 | - | - |
Enterprise Value (EV) 1 | 38.15 | 55.19 | 326.4 | 234.5 | 235.1 | 88.65 | 94.55 | 112.3 |
P/E ratio | -9.75 x | -6.63 x | -41.7 x | -8.89 x | -5.85 x | -3.29 x | -3.15 x | -4.63 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - | 560 x |
EV / Revenue | - | - | - | - | - | - | - | 560 x |
EV / EBITDA | -9.67 x | -11 x | -48.9 x | -9.64 x | -5.87 x | -2.61 x | -2.83 x | -4.19 x |
EV / FCF | - | - | -46.2 x | -3.86 x | -7.72 x | 23 x | -3.07 x | - |
FCF Yield | - | - | -2.17% | -25.9% | -12.9% | 4.36% | -32.6% | - |
Price to Book | - | - | - | - | 18.4 x | 6.17 x | 9.25 x | - |
Nbr of stocks (in thousands) | 195,660 | 208,263 | 261,133 | 293,125 | 320,857 | 303,408 | - | - |
Reference price 2 | 0.1950 | 0.2650 | 1.250 | 0.8000 | 0.7600 | 0.3700 | 0.3700 | 0.3700 |
Announcement Date | 14/02/20 | 01/02/21 | 14/02/22 | 26/01/23 | 29/01/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | 0.2003 |
EBITDA 1 | -3.947 | -5.035 | -6.669 | -24.31 | -40.06 | -33.93 | -33.36 | -26.81 |
EBIT 1 | - | - | -6.937 | -24.75 | -40.5 | -31.3 | -35.9 | -43.4 |
Operating Margin | - | - | - | - | - | - | - | -21,664.25% |
Earnings before Tax (EBT) 1 | -3.971 | -5.321 | -6.966 | -24.42 | -39 | -31.3 | -35.8 | -43.1 |
Net income 1 | -3.971 | -5.321 | -6.966 | -24.42 | -39 | -31.3 | -25.56 | -27.34 |
Net margin | - | - | - | - | - | - | - | -13,645.24% |
EPS 2 | -0.0200 | -0.0400 | -0.0300 | -0.0900 | -0.1300 | -0.1125 | -0.1175 | -0.0800 |
Free Cash Flow 1 | - | - | -7.073 | -60.76 | -30.44 | 3.861 | -30.84 | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 14/02/20 | 01/02/21 | 14/02/22 | 26/01/23 | 29/01/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: October | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA 1 | -2.373 | -5.363 | -4.822 | -5.794 | -8.334 | -8.501 | -9.699 | -10.16 | - | -9.923 | -7.7 | -7.1 | -5.8 | - | - |
EBIT | - | - | - | - | -8.452 | -8.608 | -9.808 | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | -5.831 | -8.21 | -8.015 | -9.347 | -9.932 | -11.7 | - | - | -9.336 | -9.988 | - | - |
Net income | - | - | - | -5.831 | -8.21 | -8.015 | -9.347 | -9.932 | -11.7 | - | - | -9.336 | -9.988 | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | - | -0.0200 | -0.0200 | -0.0200 | -0.0300 | -0.0300 | -0.0300 | -0.0300 | -0.0400 | -0.0300 | -0.0267 | -0.0300 | -0.0267 | -0.0300 | -0.0300 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 14/02/22 | 29/03/22 | 27/06/22 | 14/09/22 | 26/01/23 | 16/03/23 | 13/06/23 | 13/09/23 | 29/01/24 | 18/03/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | - | - | - | - | 8.72 | 23.6 | 17.7 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -7.07 | -60.8 | -30.4 | 3.86 | -30.8 | - |
ROE (net income / shareholders' equity) | - | - | - | - | -130% | - | -3,513% | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | - | 0.0400 | 0.0600 | 0.0400 | - |
Cash Flow per Share 2 | - | - | - | - | -0.1000 | -0.0700 | -0.0800 | -0.0900 |
Capex 1 | - | - | 0.23 | 46.3 | 0.1 | 0.03 | 0.1 | 0.04 |
Capex / Sales | - | - | - | - | - | - | - | 19.97% |
Announcement Date | 14/02/20 | 01/02/21 | 14/02/22 | 26/01/23 | 29/01/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.39% | 126B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
-17.50% | 4.99B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B | |
-21.88% | 1.82B |
- Stock Market
- Equities
- SVA Stock
- SVA Stock
- Financials Sernova Corp.